DNER and cancer: The prospects of targeting phosphorylation hotspots and phosphorylation-dependent sites, ET, or IDR for governing BET-dependent transcription in cancer cells are outlined in Section 2, Section 3 and Section 4, and approaches to inhibiting non-BD-dependent BET interactions with viral proteins are summarized in Section 5.